Study finds beta blockers reduce risk of death after surgery

September 29, 2010 By Steve Tokar, University of California - San Francisco

Surgical patients with known heart disease risks who are given beta blockers around the time of surgery have a significantly reduced risk of post-operative death compared with patients not given beta blockers, according to a study by researchers at the San Francisco VA Medical Center.

“We are reducing the short- and long-term risk of death after surgery by about 35 percent with beta blockers,” says lead author Arthur W. Wallace, MD, PhD, an at SFVAMC and a professor of anesthesiology at the University of California, San Francisco. “And we are doing it for a total cost of about one dollar per patient.”

Beta blockers lower heart rate by blocking the effects of , which in turn reduces the risk of chest pain or myocardial ischemia (reduced blood supply to the heart) that can occur when a rapidly beating heart does not receive adequate blood flow.

The study appears in the October 2010 issue of the journal Anesthesiology.

The analysis of 38,779 surgeries of all types performed at SFVAMC from 1996 to 2008 is the largest in a clinical setting of the protocol known as perioperative beta blockade, which calls for beta blockers to be given to surgical patients with , vascular disease, or at least two risk factors for coronary artery disease.

The study showed that surgical patients who were already taking beta blockers before surgery and had at least one dose after surgery, as well as patients not on beta blockers who were given at least one dose after , had a significantly lower 30-day and one-year post-operative mortality rate than patients who never received .

Wallace and his colleagues developed and implemented perioperative beta blockade at SFVAMC in 1998 and have helped introduce its use into general surgical practice in the United States.

“This shows what the VA medical system can do,” says Wallace. “We researched and developed a therapy that reduces perioperative mortality by 35 percent, implemented it, spread the idea to other hospitals, and thanks to the VA’s automated medical records system, we are able to demonstrate that it works safely in a very large sample of patients.”

Related Stories

Recommended for you

Fabric imbued with optical fibers helps fight skin diseases

February 23, 2018
A team of researchers with Texinov Medical Textiles in France has announced that their PHOS-ISTOS system, called the Fluxmedicare, is on track to be made commercially available later this year. The system consists of a piece ...

DNA gets away: Scientists catch the rogue molecule that can trigger autoimmunity

February 22, 2018
A research team has discovered the process - and filmed the actual moment - that can change the body's response to a dying cell. Importantly, what they call the 'Great Escape' moment may one day prove to be the crucial trigger ...

Low-calorie diet enhances intestinal regeneration after injury

February 22, 2018
Dramatic calorie restriction, diets reduced by 40 percent of a normal calorie total, have long been known to extend health span, the duration of disease-free aging, in animal studies, and even to extend life span in most ...

Gut microbes protect against sepsis—mouse study

February 22, 2018
Sepsis occurs when the body's response to the spread of bacteria or toxins to the bloodstream damages tissues and organs. The fight against sepsis could get a helping hand from a surprising source: gut bacteria. Researchers ...

Artificial intelligence quickly and accurately diagnoses eye diseases and pneumonia

February 22, 2018
Using artificial intelligence and machine learning techniques, researchers at Shiley Eye Institute at UC San Diego Health and University of California San Diego School of Medicine, with colleagues in China, Germany and Texas, ...

Fertility breakthrough: New research could extend egg health with age

February 22, 2018
Women have been told for years that if they don't have children before their mid-30s, they may not be able to. But a new study from Princeton University's Coleen Murphy has identified a drug that extends egg viability in ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.